Literature DB >> 15055239

Impact of in vivo glycation of LDL on platelet aggregation and monocyte chemotaxis in diabetic psammomys obesus.

Monika Zoltowska1, Edgard Delvin, Ehud Ziv, Noel Peretti, Manon Chartré, Emile Levy.   

Abstract

Psammomys obesus (sand rat) is an appropriate model to highlight the development of hyperinsulinemia, insulin resistance, obesity, and diabetes. This animal species, with genetically predetermined diabetes, acquires non-insulin dependent diabetes mellitus when exposed to energy-rich diets. In the present study, we explored the possibility that glycation of LDL may occur in diabetes-prone P. obesus and affect platelet and macrophage functions. The glycation of LDL, isolated from diabetic animals, was significantly (P < 0.05) higher (40%) than that of control animals. The incubation of platelets with glycated LDL enhanced the reactivity of platelets by 32-44% depending on the aggregating agents (thrombin, collagen, ADP). Furthermore, LDL derived from diabetic rats were chemotactic for normal monocytes and stimulated the incorporation of [14C]oleate into cellular cholesteryl esters. The enhancement of platelet aggregation and cholesterol esterification in monocytes may contribute toward the accelerated development of atherosclerotic cardiovascular disease in diabetic P. obesus animals. This study also illustrates the relevance of studying atherosclerosis in the P. obesus animal model, as it shows an increased tendency to develop diet-induced diabetes, which is associated with cardiovascular disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15055239     DOI: 10.1007/s11745-004-1205-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  34 in total

1.  Mechanisms of hypercholesterolaemia in glycogen storage disease type I: defective metabolism of low density lipoprotein in cultured skin fibroblasts.

Authors:  E Levy; L Thibault; C C Roy; J Letarte; M Lambert; E G Seidman
Journal:  Eur J Clin Invest       Date:  1990-06       Impact factor: 4.686

2.  Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs.

Authors:  A W Stitt; C He; S Friedman; L Scher; P Rossi; L Ong; H Founds; Y M Li; R Bucala; H Vlassara
Journal:  Mol Med       Date:  1997-09       Impact factor: 6.354

3.  Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.

Authors:  M T Quinn; S Parthasarathy; L G Fong; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  Glycated low density lipoproteins modify platelet properties: a compositional and functional study.

Authors:  G Ferretti; R A Rabini; T Bacchetti; A Vignini; E Salvolini; F Ravaglia; G Curatola; L Mazzanti
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

5.  Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages.

Authors:  R Zimmermann; U Panzenböck; A Wintersperger; S Levak-Frank; W Graier; O Glatter; G Fritz; G M Kostner; R Zechner
Journal:  Diabetes       Date:  2001-07       Impact factor: 9.461

6.  A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins.

Authors:  L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

7.  Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes.

Authors:  I Giardino; D Edelstein; M Brownlee
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

8.  Oxidation of low density lipoprotein leads to particle aggregation and altered macrophage recognition.

Authors:  H F Hoff; T E Whitaker; J O'Neil
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

9.  Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM.

Authors:  G Bellomo; E Maggi; M Poli; F G Agosta; P Bollati; G Finardi
Journal:  Diabetes       Date:  1995-01       Impact factor: 9.461

10.  Lipogenesis in the sand rat (Psammomys obesus).

Authors:  B Kalderon; J H Adler; E Levy; A Gutman
Journal:  Am J Physiol       Date:  1983-05
View more
  7 in total

Review 1.  Hyperglycemic memory in diabetic cardiomyopathy.

Authors:  Jiabing Zhan; Chen Chen; Dao Wen Wang; Huaping Li
Journal:  Front Med       Date:  2021-12-18       Impact factor: 4.592

2.  Inhibiting low-density lipoprotein glycation ameliorates increased cholesteryl ester synthesis in macrophages and hypercholesterolemia and aortic lipid peroxidation in streptozotocin diabetic rats.

Authors:  Margo P Cohen; Elizabeth A Shea; Van-Yu Wu
Journal:  Metabolism       Date:  2009-11-18       Impact factor: 8.694

Review 3.  Psammomys obesus: a Natural Diet-Controlled Model for Diabetes and Cardiovascular Diseases.

Authors:  Rajneesh Chaudhary; Ken R Walder; Christoph E Hagemeyer; Jagat R Kanwar
Journal:  Curr Atheroscler Rep       Date:  2018-07-17       Impact factor: 5.113

4.  Effects of different LDL particles on inflammatory molecules in human mesangial cells.

Authors:  E Santini; R Lupi; S Baldi; S Madec; D Chimenti; E Ferrannini; A Solini
Journal:  Diabetologia       Date:  2008-08-28       Impact factor: 10.122

Review 5.  Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.

Authors:  Margo P Cohen; Fuad N Ziyadeh; Sheldon Chen
Journal:  J Lab Clin Med       Date:  2006-05

6.  β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model.

Authors:  Ehud Zigmond; Oshrat Tayer-Shifman; Gadi Lalazar; Ami Ben Ya'acov; Sarah Weksler-Zangen; David Shasha; Miriam Sklair-Levy; Lidya Zolotarov; Zvi Shalev; Rony Kalman; Ehud Ziv; Itamar Raz; Yaron Ilan
Journal:  J Inflamm Res       Date:  2014-10-08

Review 7.  The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review.

Authors:  Sarah Louise Fishman; Halis Sonmez; Craig Basman; Varinder Singh; Leonid Poretsky
Journal:  Mol Med       Date:  2018-11-23       Impact factor: 6.354

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.